Status:
COMPLETED
Risk Factors and Diagnostic Performance of Predictors as a Screening Technique for Gestational Diabetes Mellitus
Lead Sponsor:
King Abdulaziz Medical City
Conditions:
Gestational Diabetes
Eligibility:
All Genders
Brief Summary
Background Gestational diabetes mellitus (GDM) is a condition that can have negative impacts on both mother and baby. Detecting GDM early is crucial, and fasting plasma glucose (FPG) has been suggeste...
Detailed Description
This study was a hospital-based retrospective cross-sectional study. The study was conducted at the clinic of King Abdul-Aziz Medical City, a tertiary care hospital in Jeddah, Saudi Arabia. Data were ...
Eligibility Criteria
Inclusion
- Singleton pregnant women who received prenatal care services in Obstetrics clinics at king Abdul-Aziz medical city.
Exclusion
- Pregnant known to have diabetes mellitus.
- Participant with Autoimmune disease.
Key Trial Info
Start Date :
May 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 2 2023
Estimated Enrollment :
247 Patients enrolled
Trial Details
Trial ID
NCT06109597
Start Date
May 23 2022
End Date
July 2 2023
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fatimah Khobrani
Jeddah, Saudi Arabia